Skip to main content
Media Coverage

Psychedelics for Depression: MindBio and Enveric’s Joint Efforts [TDR]

By May 15, 2024No Comments

MindBio Therapeutics (CNSX: MBIO) and Enveric Biosciences (NASDAQ: ENVB) are collaborating to advance treatments for neuropsychiatric disorders through microdosing psychedelics, such as their novel psilocin prodrug candidates. This partnership represents a significant move toward utilizing psychedelic medicines to manage mental health disorders without the typical hallucinogenic effects.

Full Article >>